Last updated: July 9, 2024
Sponsor: Dr.dr.Irma Bernadette, SpKK (K)
Overall Status: Active - Recruiting
Phase
N/A
Condition
Aging
Skin Aging
Treatment
Leucocyte Telomere Length from blood draw
Clinical Study ID
NCT06501547
tes
Ages 29-61 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female and Male (age 29-31 years old and 59-61 years old
signs of aging
Exclusion
Exclusion Criteria:
pregnant or breastfeeding
have disease or genetic problem
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Leucocyte Telomere Length from blood draw
Phase:
Study Start date:
October 01, 2023
Estimated Completion Date:
September 01, 2024
Study Description
Connect with a study center
Universitas Indonesia
Jakarta Pusat, DKI Jakarta 10430
IndonesiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.